Clinical trial
A Multicenter, Non-Drug Interventional Study for the Technical Development and Validation of the Nocturnal Scratch Algorithm for Use in Future Programs
NCT04262791 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Non-Drug Interventional Study for the Technical Development and Validation of the Nocturnal Scratch Algorithm for Use in Future Programs
- Lead sponsor
- AbbVie
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 17, 2020
- Completion date
- January 31, 2022
- Enrollment
- 16 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis